The PlayBeyondBio initiative has selected nine Israeli startups for its program for companies developing solutions for future challenges to healthcare systems. C2i Genomics, Nucleai, Itamar medical, Medial Earlysign, iBex, Octopus.health, Imagene, iCardio.ai and Cordio Medical. https://www.calcalistech.com/ctech/articles/0,7340,L-3912456,00.html

The US National Sleep Foundation (NSF) has chosen Israel’s Itamar Medical.(reported here previously) as the winner of its 2020 SleepTech Award, which recognizes the year’s most innovative achievement in sleep technology. Itamar’s WatchPAT ONE diagnoses sleep apnea. https://www.timesofisrael.com/itamar-medicals-sleep-apnea-device-wins-us-national-sleep-foundation-award/  

Israel’s Itamar Medical (reported here previously) is funding a trial of its disposable WatchPAT ONE CPAP device. It will be given to 200 confirmed or suspected COVID-19 patients in the Mount Sinai Health (US) system with respiratory symptoms but who … Continue reading →

The US FDA has approved the use of the WatchPAT Sleep Apnea device from Israel’s Itamar Medical being extended to adolescents of twelve years old and above.  Previously, WatchPAT was only approved for use on those aged seventeen and above. … Continue reading →

At the 13th International Dead Sea Symposium on Innovations in Technology, Treatment & Prevention of Cardiac Arrhythmias, Israel’s Itamar Medical announced that 60 international hospitals have now adopted Itamar’s Total Sleep Solution.  (see 17th May newsletter) http://www.timesofisrael.com/how-sleep-apnea-causes-heart-attacks-and-how-israeli-tech-helps/

Evidence linking cardiovascular disease and obstructive sleep apnea (OSA) has prompted Israel’s Itamar Medical to offer a Total Sleep Solution (TSS) to US hospitals and clinics. TSS links Itamar’s WatchPAT home sleep test with nationwide diagnostic testing facilities, sleep physicians … Continue reading →

Israel’s Itamar Medical manufactures the EndoPAT diagnostic device that measures how well your arteries are working. Japan’s Nihon Kohden will market EndoPAT to 100,000 doctors in Japan as its flagship product for monitoring the heart and blood vessels. http://www.globes.co.il/en/article-itamar-medical-signs-distribution-agreement-in-japan-1000947940

Israel’s Itamar Medical has signed an exclusive marketing agreement with Medtronic Corporation to market the company’s sleep apnea diagnostic product to a select segment of the US market – patients with atrial fibrillation.. http://www.globes.co.il/en/article-itamar-signs-medtronic-distribution-deal-for-sleep-device–1000925010